ClinicalTrials.Gov Participation Is Up From 2002 Rate Of 35%, FDA Report Says
This article was originally published in The Pink Sheet Daily
Executive SummaryAgency calls participation in ClinicalTrials.gov "mixed," despite recent increase in use.
You may also be interested in...
Anand Shah returns to FDA as deputy commissioner; like Abernethy, he is an oncologist with a background in big data.
Resubmission comes more than four years after Purdue pulled an sNDA seeking to demonstrate ‘real-world’ abuse prevention.